Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Angina pectoris Stories

2013-07-10 08:27:57

ATLANTA, July 10, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration (FDA) premarket approval for its new Sologrip(®) minimally invasive laser fiber-optic delivery system. The Sologrip delivery system is a single-use, disposable handset designed for use with the Company's Cardiogenesis transmyocardial revascularization...

2013-06-12 23:21:18

Our Lady of Lourdes Medical Center and The Heart House participate in clinical study to determine whether a patient´s own stem cells can relieve chronic chest pain caused by coronary artery disease. Camden, New Jersey (PRWEB) June 12, 2013 Our Lady of Lourdes Medical Center and The Heart House are participating in a clinical study to determine whether a patient´s own (autologous), adult, stem cells are safe and can relieve chronic chest pain caused by coronary artery disease, as...

2013-05-21 08:28:33

-Initial Data from Patient Registries Shows the Reducer Significantly Improves Angina Scores at Six Months Post-Implantation- TSX Venture Exchange: NVC PARIS and VANCOUVER, May 21, 2013 /CNW/ - Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat vascular disease, today reported initial data from open label patient Registries that are tracking the progress of refractory angina patients implanted with the Neovasc Reducer(TM), a novel percutaneous device that...

2013-05-13 08:28:25

-Full Data from COSIRA Trial Expected Around Year's End--Initial Data from Reducer Patient Registries To Be Presented at EuroPCR 2013- TSX Venture Exchange: NVC VANCOUVER, May 13, 2013 /CNW/ - Neovasc Inc. (TSXV: NVC), today announced the completion of patient enrollment in its COSIRA trial designed to further assess the efficacy and safety of the Neovasc Reducer(TM), a novel percutaneous device for the treatment of refractory angina.  The COSIRA (Coronary Sinus Reducer for...

2013-05-06 11:20:01

A new stress test protocol that investigates reducing the use of perfusion imaging in low risk patients undergoing SPECT myocardial perfusion imaging for possible angina symptoms was found to be diagnostically safe, revealed a US retrospective analysis. The study, reported as an abstract´ at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC11) May 5 to May 8 in Berlin, Germany, predicted that using exercise ECG stress testing alone in patients with high exercise...

2013-05-02 23:25:12

Research conducted by the Mayo Clinic found that L-carnitine, such as that found in Liproxenol, the popular weight loss supplement which was developed by Liproxenol Pharmaceuticals, can likely reduce a person´s risk of premature death, as well as lower their arrhythmias and angina attacks. Australia (PRWEB) May 02, 2013 With heart disease being the top cause of death in the U.S., scientists have spent hundreds of thousands of hours and dollars trying to figure out how to lower this way...

2013-03-22 23:04:43

GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol of California. Sacramento, CA (PRWEB) March 22, 2013 GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol hosted by Assemblyman Don Wagner, R-Irvine and Assemblywoman Diane Harkey, R-Dana Point to celebrate the State...

2013-03-18 20:45:39

In people with chest pain originating from heart disease Higher levels of pregnancy-associated plasma protein A (PAPP-A) were associated with an increased risk of cardiovascular events in people with cardiac chest pain that developed as a result of heart disease/coronary artery disease, according to a study published in CMAJ. PAPP-A, used to screen for Down syndrome in pregnant women, has been suggested as a marker of unstable plaque in coronary arteries. The study was conducted in...

Job Burnout Compromises Heart Health
2013-03-13 06:20:35

April Flowers for redOrbit.com - Your Universe Online More so than in many industrialized nations, Americans work longer hours, take fewer vacation days and retire later in life. It is not surprising, therefore, that with such demanding careers many experience job burnout expressed as physical, cognitive and emotional exhaustion resulting from stress at work. Previous studies have found that burnout is also related to obesity, insomnia and anxiety. A new study from Tel Aviv University's...

2013-03-12 23:01:16

Pain reduction effects of ranolazine most pronounced in patients with poor glucose control A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both...